Transcriptomic signatures of brain regional vulnerability to Parkinson’s disease
Authors:
- Arlin KeoAKArlin Keo
- Ahmed MahfouzAMAhmed Mahfouz
- Thomas ComptdaerTCThomas Comptdaer
- Boudewijn P. F. LelieveldtBLBoudewijn P. F. Lelieveldt
- Martin FigeacMFMartin Figeac
- Marie-Christine Chartier-HarlinMCMarie-Christine Chartier-Harlin
- Wilma D. J. van de BergWBWilma D. J. van de Berg
- Jacobus J. van HiltenJHJacobus J. van Hilten
Open Access
- 5 March 2020
- journal article
- research article
- Published by Springer Nature in Communications Biology
- Vol. 3 (1) , 1-12
Abstract
The molecular mechanisms underlying caudal-to-rostral progression of Lewy body pathology in Parkinson’s disease remain poorly understood. Here, we identified transcriptomic signatures across brain regions involved in Braak Lewy body stages in non-neurological adults from the Allen Human Brain Atlas. Among the genes that are indicative of regional vulnerability, we found known genetic risk factors for Parkinson’s disease: SCARB2, ELOVL7, SH3GL2, SNCA, BAP1, and ZNF184. Results were confirmed in two datasets of non-neurological subjects, while in two datasets of Parkinson’s disease patients we found altered expression patterns. Co-expression analysis across vulnerable regions identified a module enriched for genes associated with dopamine synthesis and microglia, and another module related to the immune system, blood-oxygen transport, and endothelial cells. Both were highly expressed in regions involved in the preclinical stages of the disease. Finally, alterations in genes underlying these region-specific functions may contribute to the selective regional vulnerability in Parkinson’s disease brains.Keywords
All Related Versions
This publication has 52 references indexed in Scilit:
- Design of a Single AAV Vector for Coexpression of TH and GCH1 to Establish Continuous DOPA Synthesis in a Rat Model of Parkinson's DiseaseMolecular Therapy, 2012
- Transcriptional profile of Parkinson blood mononuclear cells with LRRK2 mutationNeurobiology of Aging, 2011
- Quality control parameters on a large dataset of regionally dissected human control brains for whole genome expression studiesJournal of Neurochemistry, 2011
- α-Synuclein and dopamine at the crossroads of Parkinson's diseaseTrends in Neurosciences, 2010
- Anemia or low hemoglobin levels preceding Parkinson diseaseNeurology, 2009
- WGCNA: an R package for weighted correlation network analysisBMC Bioinformatics, 2008
- α-synuclein locus duplication as a cause of familial Parkinson's diseaseThe Lancet, 2004
- α-Synuclein Locus Triplication Causes Parkinson's DiseaseScience, 2003
- Staging of brain pathology related to sporadic Parkinson’s diseaseNeurobiology of Aging, 2003
- Mice Lacking α-Synuclein Display Functional Deficits in the Nigrostriatal Dopamine SystemNeuron, 2000